Anna Chu
Biographic Data
| ID | 366842 |
|---|---|
| NAME | Anna Chu |
| GIVEN NAMES | Anna |
| FAMILY NAME | Chu |
| SIGNATURE | CHU A |
| AFFILIATIONS | Public Health Ontario |
| ORCID | 0000-0003-4614-7684 |
| VERIFIED | Yes |
| TOTAL WORKS | 6 |
| TOTAL CITATIONS | 6 |
| AUTHOR COUNT | 6 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 1 |
He Huarahi Hou: Exploring the genesis of a unique approach and design of a regional pharmacopoeia
This article advances a tangata whenua (local people, Indigenous people of the land) worldview of rongoā (medicine) and explores a new approach for an Indigenous regional pharmacopoeia for Te Tauihu—top of the South Island of Aotearoa New Zealand. Wānanga (Māori [the Indigenous peoples of New Zealand]-led learning sessions) focused on rongoā Māori (traditional healing system of Māori) and research reviewing traditional medicines and Indigenous ph…
Rising out-of-hospital mortality in Canada during 2020‒2022: A striking impact observed among young adults
Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with Covid-19: A population-based cohort study
The mortality risk in COVID-19 increases with age and comorbidity but the prognostic implications varied by sex and condition. These observations can support communication efforts and inform vaccine rollout in jurisdictions with limited vaccine supplies
Assessing the Relative Timeliness of Ontario’s Syndromic Surveillance Systems for Early Detection of the 2009 Influenza H1N1 Pandemic Waves
Pandemic H1N1 in Canada and the use of evidence in developing public health policies - A policy analysis
The use of syndromic surveillance for decision-making during the H1N1 pandemic: A qualitative study
Syndromic surveillance had limited use in decision-making during the 2009 H1N1 pandemic in Ontario. This study provides insights into the reasons why this occurred. Despite this, syndromic data were valued for providing situational awareness and confidence to support public communications and recommendations. Developing an understanding of how syndromic data are utilized during public health events provides valuable evidence to support future inv…
The use of syndromic surveillance for decision-making during the H1N1 pandemic: A qualitative study
Syndromic surveillance had limited use in decision-making during the 2009 H1N1 pandemic in Ontario. This study provides insights into the reasons why this occurred. Despite this, syndromic data were valued for providing situational awareness and confidence to support public communications and recommendations. Developing an understanding of how syndromic data are utilized during public health events provides valuable evidence to support future inv…
Assessing the Relative Timeliness of Ontario’s Syndromic Surveillance Systems for Early Detection of the 2009 Influenza H1N1 Pandemic Waves
Pandemic H1N1 in Canada and the use of evidence in developing public health policies - A policy analysis
Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with Covid-19: A population-based cohort study
The mortality risk in COVID-19 increases with age and comorbidity but the prognostic implications varied by sex and condition. These observations can support communication efforts and inform vaccine rollout in jurisdictions with limited vaccine supplies
Rising out-of-hospital mortality in Canada during 2020‒2022: A striking impact observed among young adults
He Huarahi Hou: Exploring the genesis of a unique approach and design of a regional pharmacopoeia
This article advances a tangata whenua (local people, Indigenous people of the land) worldview of rongoā (medicine) and explores a new approach for an Indigenous regional pharmacopoeia for Te Tauihu—top of the South Island of Aotearoa New Zealand. Wānanga (Māori [the Indigenous peoples of New Zealand]-led learning sessions) focused on rongoā Māori (traditional healing system of Māori) and research reviewing traditional medicines and Indigenous ph…
Medicine (6 works) · Coronavirus disease 2019 (COVID-19 (3 works) · COVID-19 epidemiological studies (3 works) · Disease (3 works) · Pandemic (3 works) · COVID-19 and healthcare impacts (2 works) · Data-Driven Disease Surveillance (2 works) · Demography (2 works) · Demography (2 works) · Environmental health (2 works)